Overview
Steven Larmon is a Hematologist Oncology specialist and a Hematologist in Keene, New Hampshire. Dr. Larmon is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Parkland Physician Services Inc
Zachary Spigelman is a Hematologist Oncology specialist and a Hematologist in Derry, New Hampshire. Dr. Spigelman is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Thrombocytopenia, Small Cell Lung Cancer (SCLC), Monoclonal Gammopathy of Undetermined Significance (MGUS), and Lung Cancer.
Berkshire Faculty Services Inc
Trevor Bayliss is a Hematologist Oncology specialist and a Hematologist in Pittsfield, Massachusetts. Dr. Bayliss is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Paget Disease of the Breast, and Colorectal Cancer. Dr. Bayliss is currently accepting new patients.
Lgh Medical Group, Inc.
Michael Coyle is a Hematologist Oncology specialist and a Hematologist in Lowell, Massachusetts. Dr. Coyle has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Anemia. Dr. Coyle is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Larmon isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung AdenocarcinomaDr. Larmon isDistinguished. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Dr. Larmon isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Larmon isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Chronic Lymphocytic Leukemia (CLL)
- EGFR Positive Lung CancerDr. Larmon isAdvanced. Learn about EGFR Positive Lung Cancer.
- Familial Prostate CancerDr. Larmon isAdvanced. Learn about Familial Prostate Cancer.
- Inflammatory Breast CancerDr. Larmon isAdvanced. Learn about Inflammatory Breast Cancer.
- Large-Cell Lung CarcinomaDr. Larmon isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Multiple MyelomaDr. Larmon isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Adult Immune ThrombocytopeniaDr. Larmon isExperienced. Learn about Adult Immune Thrombocytopenia.
- AnemiaDr. Larmon isExperienced. Learn about Anemia.
- AngiosarcomaDr. Larmon isExperienced. Learn about Angiosarcoma.
- Bladder CancerDr. Larmon isExperienced. Learn about Bladder Cancer.
- Blood ClotsDr. Larmon isExperienced. Learn about Blood Clots.
- Breast CancerDr. Larmon isExperienced. Learn about Breast Cancer.